Su Been Lee
Overview
Explore the profile of Su Been Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
359
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarpatwari A, Lu Z, Russo M, Zakoul H, Lee S, Toyserkani G, et al.
JAMA Netw Open
. 2025 Feb;
8(2):e2459311.
PMID: 39946132
Importance: Clozapine is an effective medication for treatment-resistant schizophrenia but can cause agranulocytosis. Since its approval, patients taking clozapine have been required to undergo regular blood testing to screen for...
2.
Desai R, Varma V, Mahesri M, Lee S, Freedman A, Gerhard T, et al.
Clin Pharmacol Ther
. 2025 Feb;
PMID: 39935003
We evaluated whether drugs approved for other indications that also target metabolic drivers of Alzheimer's disease and related dementia (ADRD) pathogenesis are associated with delayed onset of ADRD. Using routinely...
3.
Khan N, Kim S, Lee S, Bykov K, Paik J
Clin J Am Soc Nephrol
. 2024 Dec;
20(1):31-38.
PMID: 39665574
No abstract available.
4.
Mahesri M, Lee S, Levin R, Imren S, Zhang L, Beukelman T, et al.
Clin Pharmacol Ther
. 2024 Sep;
116(6):1572-1579.
PMID: 39328080
The CRISPR-based gene editing therapy exagamglogene autotemcel (exa-cel) recently received FDA approval for patients with severe sickle cell disease (SCD). The approval was based on a phase III trial (CLIMB...
5.
Ko D, Lin K, Lee S, Lu Z, Cheng S, Shah S, et al.
Drugs Aging
. 2024 Sep;
41(9):763-773.
PMID: 39259265
Background And Objective: Prospective sequential analyses after a new drug approval allow proactive surveillance of new drugs. In the current study, we demonstrate feasibility of frailty-specific sequential analyses for dabigatran,...
6.
DAndrea E, Schneeweiss S, Franklin J, Kim S, Glynn R, Lee S, et al.
Arthritis Rheumatol
. 2024 Aug;
77(1):12-21.
PMID: 39129266
Objective: The objective of this study is to evaluate the concordance of results between the Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly (HORIZON)-Pivotal Fracture Trial (PFT) and...
7.
Ko D, Evans P, Lin K, Pande A, Cervone A, Lee S, et al.
J Am Heart Assoc
. 2024 Jul;
13(15):e034529.
PMID: 39056329
Background: Ticagrelor is recommended over clopidogrel in acute coronary syndrome based on the results of the PLATO (Study of Platelet Inhibition and Patient Outcomes) trial. We aimed to emulate PLATO...
8.
Feldman W, Mahesri M, Sarpatwari A, Huybrechts K, Zhu Y, Hwang C, et al.
JAMA Netw Open
. 2024 Jul;
7(7):e2419873.
PMID: 39023895
Importance: Endothelin receptor antagonists are first-line therapy for pulmonary arterial hypertension (PAH). The first 2 agents approved in the class, bosentan and ambrisentan, initially carried boxed warnings for hepatotoxicity and...
9.
Lee S, Park C, Levin R, Kim D
J Am Geriatr Soc
. 2024 Jul;
72(11):3484-3491.
PMID: 38979845
Background: Sleep aids are commonly prescribed to treat sleep disturbance, a modifiable risk factor for postoperative delirium in older patients. The use of melatonin receptor agonists in the postoperative period...
10.
Im Y, Lee K, Lee S, Kim K, Park K
Investig Clin Urol
. 2024 Jul;
65(4):391-399.
PMID: 38978219
Purpose: The management of bowel bladder disorder (BBD) has only been indicated for subjective constipation without objective evidence. We attempted to highlight the radiological findings in patients with BBD and...